Highlights and Quick Summary
- EBITDA for the quarter ending March 31, 2023 was $-21.8 Million (a 8.42% increase compared to previous quarter)
- Year-over-year quarterly EBITDA increased by 7.24%
- Annual EBITDA for 2022 was $-62.6 Million (a -4.01% decrease from previous year)
- Annual EBITDA for 2021 was $-65.2 Million (a 32.63% increase from previous year)
- Annual EBITDA for 2020 was $-49.2 Million (a -7.93% decrease from previous year)
- Twelve month EBITDA ending March 31, 2023 was $-68 Million (a 12.66% increase compared to previous quarter)
- Twelve month trailing EBITDA decreased by -1.26% year-over-year
31 Mar '23 | 31 Dec '22 | 30 Sep '22 | 30 Jun '22 |
---|---|---|---|
$-68 Million | $-60.4 Million | $-60.1 Million | $-68.9 Million |
Historical EBITDA of Precigen, Inc.
Most recent EBITDAof PGEN including historical data for past 10 years.Interactive Chart of EBITDA of Precigen, Inc.
Precigen, Inc. EBITDA for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
---|---|---|---|---|---|
2023 | $-21.77 | – | – | – | – |
2022 | $-20.08 | $-5.9 | $-20.3 | $-14.12 | $-62.61 |
2021 | $-19.76 | $-14.73 | $-19.38 | $-11.36 | $-65.22 |
2020 | $-28.33 | $-16.34 | $4.91 | $-9.4 | $-49.17 |
2019 | $50.55 | $-33.2 | $-28.91 | $-41.85 | $-53.41 |
2018 | $-188.48 | $-49.04 | $-22.05 | $-43.17 | $-302.75 |
2017 | $30.41 | $-38.85 | $-36.33 | $-22.16 | $-66.94 |
2016 | $-11.96 | $-22.99 | $6.55 | $-12.23 | $-40.63 |
2015 | $-30.99 | $27.48 | $7.06 | $-198.9 | $-195.36 |
2014 | $-53.66 | $25.47 | $18.04 | $-37.58 | $-47.72 |
2013 | $-20.26 | $-37.41 | $-20.11 | $17.23 | $-60.55 |
2012 | $-10.48 | $-21.25 | – | – | $-60.88 |